Patient info Open main menu

Aripiprazole Liconsa 10 mg tablets – patient leaflet, side effects, dosage

Medicine status: Prescription only (POM) Details

Medicine strength:
10 mg
Contains active substance:

Patient leaflet - Aripiprazole Liconsa 10 mg tablets

s. how to store aripiprazole

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the blister and on the carton after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. contents of the pack and other infomation

What Aripiprazole tablets contains

  • The active substance is aripiprazole. Aripiprazole 5 mg tablets: Each tablet contains 5 mg of aripiprazole.

Aripiprazole 10 mg tablets: Each tablet contains 10 mg of aripiprazole.

Aripiprazole 15 mg tablets: Each tablet contains 15 mg of aripiprazole.

Aripiprazole 30 mg tablets: Each tablet contains 30 mg of aripiprazole.

  • The other ingredients are lactose monohydrate, maize starch, microcrystalline cellulose, hydroxypropyl cellulose, magnesium stearate, red iron oxide (E172).

Facts about Aripiprazole Liconsa 10 mg tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Aripiprazole
Strength 10 mg
Pharmaceutical form Oral tablet
Aripiprazole Liconsa 10 mg tablets: Round biconvex pale pink tablet (diameter 7 mm).
How is it taken Oral
Excipients Lactose monohydrate, Maize starch, Microcrystalline cellulose, Hydroxypropyl cellulose, Magnesium stearate, Red Iron Oxide (E172)
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Other antipsychotics
  1. N Nervous system drugs
    1. N05 Psycholeptics
      1. N05A Antipsychotics
        1. N05AX Other antipsychotics
          1. N05AX12 aripiprazole
Marketing authorisation PL 23218/0127 (first authorised 23 June 2020)
Marketing authorisation holder Laboratorios Liconsa, S.A.
Codes BNF 04020100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.